RELATIONSHIP BETWEEN VASCULAR FUNCTION, VENTRICULAR-VASCULAR COUPLING AND PERIPHERAL PRESSURE PULSATILITY IN HYPERTROPHIC CARDIOMYOPATHY  by Warner, Patrick J. et al.
E334
JACC April 5, 2011
Volume 57, Issue 17
  CARDIAC FUNCTION AND HEART FAILURE 
RELATIONSHIP BETWEEN VASCULAR FUNCTION, VENTRICULAR-VASCULAR COUPLING AND 
PERIPHERAL PRESSURE PULSATILITY IN HYPERTROPHIC CARDIOMYOPATHY
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 3:30 p.m.-4:45 p.m.
Session Title: Cardiomyopathies/Myocarditis/Pericardial Disease
Abstract Category: 22. Cardiomyopathies/Myocarditis/Pericardial Disease
Session-Poster Board Number: 1119-25
Authors: Patrick J. Warner, Heather Nickerson, Eshan Patvardhan, Martin Maron, Craig Napolitano, Jenny Ruan, Kevin Heffernan, Richard Karas, 
Jeffrey Kuvin, Tufts Medical Center Vascular Function Study Group, Boston, MA
Background:  Patients with hypertrophic cardiomyopathy (HCM) have coronary and peripheral conduit vascular dysfunction. Interestingly, 
peripheral microvascular function is preserved in patients with HCM. The etiology for this heterogeneity between vascular beds in vascular function 
in HCM is unclear. Therefore, we examined the role of ventricular-vascular coupling (VVC), pressure pulsatility, and microvascular function in a HCM 
population.
Methods:  We studied 50 patients with HCM (without left ventricular (LV) outflow tract obstruction at rest or during exercise) and 50 control 
subjects (without HCM devoid of coronary artery disease, CAD-), matched for age, height, weight, gender, blood pressure, heart rate, and other 
cardiovascular risk factors (i.e. diabetes mellitus, dyslipidemia, smoking). Forty-four patients without HCM with CAD+ served as positive controls 
for vascular dysfunction. Pulse volume waves were measured using finger plethysmography (peripheral artery tonometry, PAT) and used to calculate 
augmentation index (AIx, a measure of VVC) and the reactive hyperemia index (RHI, a measure of microvascular function). Pulsatility was calculated 
as pulse pressure / mean arterial pressure.
Results:  PAT-RHI was preserved in HCM (2.07±1.0 vs. 2.16±0.09%, HCM vs. CAD- controls respectively, p = 0.787). Both HCM and CAD- had higher 
PAT-RHI than CAD+ (1.69±0.08%, p<0.05). PAT-AIx was similar between HCM and CAD- controls (5.6±3.0 vs. 6.3±2.8%, p = 0.985). Both HCM and 
CAD- had lower PAT-AIx than CAD+ (18.6±2.9%, p<0.05). Pulsatility was similar between HCM and CAD- controls (0.53±0.02 vs. 0.55±0.02, p = 
0.655). Both HCM and CAD- patients had lower pulsatility than CAD+ patients (0.64±0.02, p<0.05).
Conclusions:  In addition to preserved microvascular function, our findings suggest that patients with HCM have preserved VVC and low peripheral 
pressure pulsatility. VVC in HCM may attenuate the propagation of potentially deleterious pulsatile pressure into the peripheral vasculature, which 
may, in turn, stave downstream vascular damage and preserve microvascular function in HCM.
